Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC)
Author:
Affiliation:
1. Department of Urology; Medical University of Vienna; Vienna
2. Department of Clinical Pathology; Medical University of Vienna; Vienna
3. Department of Urology; LKH Weinviertel- Korneuburg; Korneuburg; Austria
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12067/fullpdf
Reference28 articles.
1. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma;Zisman;J Clin Oncol,2002
2. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis;Park;BJU Int,2012
3. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma;Kim;Urology,2011
4. EAU guidelines on renal cell carcinoma: the 2010 update;Ljungberg;Eur Urol,2010
5. Neoadjuvant and adjuvant treatment of renal cell carcinoma;Thillai;Expert Rev Anticancer Ther,2012
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry;Clinical Genitourinary Cancer;2024-06
2. A retrospective cohort study of the impact of peripheral blood gamma- delta T cells to prognosis of nonmetastatic renal cell cancer after curative resection;Urologic Oncology: Seminars and Original Investigations;2023-12
3. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images;The Journal of Gene Medicine;2023-05-02
4. Complexity in radiological morphology predicts worse prognosis and is associated with an increase in proteasome component levels in clear cell renal cell carcinoma;Frontiers in Oncology;2022-12-08
5. C-reactive protein kinetics to predict recurrence of high-risk renal cell carcinoma after radical surgery;International Journal of Clinical Oncology;2022-02-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3